Physicians' Academy for Cardiovascular Education

CV outcomes with medicines to control glycemia: highlights from recently completed trials

Feb. 2, 2016 - VBWG, Orlando - Darren K. McGuire, MD

Video navigation menu

  • Altered rules for the development of diabetes drugs 0:02
  • Data of 5 CV outcomes trials have now been published 0:46
  • CV neutrality in trials testing DPP4-inhibitors vs. placebo 0:59
  • Also adequate CV safety with GLP-1 receptor agonist 1:23
  • Superiority for CV outcomes with a new class of antidiabetic treatment: the SGLT2-antagonist 1:47